Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDM36
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $226,749
Award facts
- Contract value 100% obligated
- $226,748.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $226,748.74 by the Defense Logistics Agency (DLA) on September 28, 2025. The contract calls for the delivery of Keytruda 100 mg/4 mL vials and is scheduled for completion by October 20, 2025. This delivery order was issued without a set-aside designation and represents a direct supply of this oncology pharmaceutical product to support Department of Defense healthcare facilities.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499.9 billion and remains valid through November 2026. The IDC authorizes the DLA to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively across a diverse range of medical product categories serving the Department of Defense's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FDM36?
SPE2DB25FDM36 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 28, 2025.
How much is contract SPE2DB25FDM36 worth?
The government has obligated $226,749 on SPE2DB25FDM36.
Is contract SPE2DB25FDM36 an order under another contract?
Yes. SPE2DB25FDM36 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM36 competed?
The extent of competition for SPE2DB25FDM36 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award